Literature DB >> 26936998

Identification of Synaptotagmin 10 as Effector of NPAS4-Mediated Protection from Excitotoxic Neurodegeneration.

Anne M H Woitecki1, Johannes Alexander Müller1, Karen M J van Loo1, Ramona F Sowade1, Albert J Becker1, Susanne Schoch2.   

Abstract

Neuronal degeneration represents a pathogenetic hallmark after different brain insults, such as ischemia and status epilepticus (SE). Excessive release of glutamate triggered by pathophysiologic synaptic activity has been put forward as key mechanism in this context. In response to pathophysiologic synaptic activity, multiple signaling cascades are activated that ultimately initiate expression of specific sets of genes, which may decide between neuronal survival versus death. Recently, a core set of genes ["activity-regulated inhibitor of death" (AID) genes] including the transcription factor (TF) NPAS4 (neuronal PAS domain protein 4) has been found to provide activity-induced protection against neuronal death caused by excitotoxic stimulation. However, the downstream targets of AID action mediating neuroprotection remained so far unknown. Here, we have identified synaptotagmin 10 (Syt10), a vesicular Ca(2+) sensor, as the first neuroprotective effector protein downstream of the TF NPAS4. The expression of Syt10 is strongly upregulated by pathophysiologic synaptic activity after kainic acid (KA) exposure and its absence renders mouse hippocampal neurons highly susceptible to excitotoxic insults. We found NPAS4 as critical for the increase in Syt10 levels and in turn the ability of NPAS4 to confer neuroprotection against KA-induced excitotoxicity to be severely diminished in Syt10 knock-out neurons. In summary, our results point to an important role for signaling of the NPAS4-Syt10 pathway in the neuronal response to strong synaptic activity as a consequence of excitotoxic insults. SIGNIFICANCE STATEMENT: Aberrant synaptic activity is observed in many neurological disorders and has been suggested as an important factor contributing to the pathophysiology. Intriguingly, pathophysiologic activity can also trigger signaling cascades mediating potentially compensatory neuroprotection against excitotoxic insult. Here, we identify a new neuroprotective signaling cascade involving the activity-induced transcriptional regulator NPAS4 and the vesicular Ca(2+)-sensor protein synaptotagmin 10 (Syt10). Syt10 is required for NPAS4 to protect hippocampal neurons against excitotoxic cell death. NPAS4 in turn controls the activity of the Syt10 gene, which is strongly induced by pathophysiologic activity. Our results uncover an entirely unexpected, novel function of Syt10 underlying the response of neurons to pathophysiologic activity and provide new therapeutic perspectives for neurological disorders.
Copyright © 2016 the authors 0270-6474/16/362561-10$15.00/0.

Entities:  

Keywords:  cell death; neuroprotection; neurotoxicity; synaptic activity; transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 26936998      PMCID: PMC6604865          DOI: 10.1523/JNEUROSCI.2027-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

Review 1.  Synaptotagmins: why so many?

Authors:  Thomas C Südhof
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

2.  Alterations in IGF-I, BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration.

Authors:  Ilias Kazanis; Margaret Giannakopoulou; Helen Philippidis; Fotini Stylianopoulou
Journal:  Exp Neurol       Date:  2004-04       Impact factor: 5.330

3.  Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.

Authors:  Allison D Ebert; Amy J Beres; Amelia E Barber; Clive N Svendsen
Journal:  Exp Neurol       Date:  2007-10-04       Impact factor: 5.330

4.  Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation.

Authors:  Zhaolan Zhou; Elizabeth J Hong; Sonia Cohen; Wen-Ning Zhao; Hsin-Yi Henry Ho; Lauren Schmidt; Wen G Chen; Yingxi Lin; Erin Savner; Eric C Griffith; Linda Hu; Judith A J Steen; Charles J Weitz; Michael E Greenberg
Journal:  Neuron       Date:  2006-10-19       Impact factor: 17.173

Review 5.  Insulin-like growth factor-1 and post-ischemic brain injury.

Authors:  J Guan; L Bennet; P D Gluckman; A J Gunn
Journal:  Prog Neurobiol       Date:  2003-08       Impact factor: 11.685

Review 6.  Targeting insulin-like growth factor-1 to treat Alzheimer's disease.

Authors:  Ignacio Torres-Aleman
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

7.  IGF-1 receptor-mediated ERK/MAPK signaling couples status epilepticus to progenitor cell proliferation in the subgranular layer of the dentate gyrus.

Authors:  Yun-Sik Choi; Hee-Yeon Cho; Kari R Hoyt; Janice R Naegele; Karl Obrietan
Journal:  Glia       Date:  2008-05       Impact factor: 7.452

Review 8.  The insulin-like growth factor system in multiple sclerosis.

Authors:  Daniel Chesik; Nadine Wilczak; Jacques De Keyser
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

9.  The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats.

Authors:  Xin-Feng Liu; John R Fawcett; Leah R Hanson; William H Frey
Journal:  J Stroke Cerebrovasc Dis       Date:  2004 Jan-Feb       Impact factor: 2.136

10.  Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

Authors:  Brian K Kaspar; Jerònia Lladó; Nushin Sherkat; Jeffrey D Rothstein; Fred H Gage
Journal:  Science       Date:  2003-08-08       Impact factor: 47.728

View more
  15 in total

1.  Post-injury Nose-to-Brain Delivery of Activin A and SerpinB2 Reduces Brain Damage in a Mouse Stroke Model.

Authors:  Bettina Buchthal; Ursula Weiss; Hilmar Bading
Journal:  Mol Ther       Date:  2018-07-23       Impact factor: 11.454

2.  Copy number variation analysis in 83 children with early-onset developmental and epileptic encephalopathy after targeted resequencing of a 109-epilepsy gene panel.

Authors:  Kyoko Hirabayashi; Daniela Tiaki Uehara; Hidetoshi Abe; Atsushi Ishii; Keiji Moriyama; Shinichi Hirose; Johji Inazawa
Journal:  J Hum Genet       Date:  2019-08-30       Impact factor: 3.172

Review 3.  Histone deacetylase-3: Friend and foe of the brain.

Authors:  Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

4.  SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility.

Authors:  Katri Silvennoinen; Kinga Gawel; Despina Tsortouktzidis; Albert J Becker; Camila V Esguerra; Sanjay M Sisodiya; Julika Pitsch; Saud Alhusaini; Karen M J van Loo; Richard Picardo; Zuzanna Michalak; Susanna Pagni; Helena Martins Custodio; James Mills; Christopher D Whelan; Greig I de Zubicaray; Katie L McMahon; Wietske van der Ent; Karolina J Kirstein-Smardzewska; Ettore Tiraboschi; Jonathan M Mudge; Adam Frankish; Maria Thom; Margaret J Wright; Paul M Thompson; Susanne Schoch
Journal:  Acta Neuropathol       Date:  2022-05-12       Impact factor: 15.887

5.  Genetic study links components of the autonomous nervous system to heart-rate profile during exercise.

Authors:  Niek Verweij; Yordi J van de Vegte; Pim van der Harst
Journal:  Nat Commun       Date:  2018-03-01       Impact factor: 14.919

Review 6.  Synapse development organized by neuronal activity-regulated immediate-early genes.

Authors:  Seungjoon Kim; Hyeonho Kim; Ji Won Um
Journal:  Exp Mol Med       Date:  2018-04-09       Impact factor: 8.718

7.  Heterogeneity and Development of Fine Astrocyte Morphology Captured by Diffraction-Limited Microscopy.

Authors:  Daniel Minge; Cátia Domingos; Petr Unichenko; Charlotte Behringer; Alberto Pauletti; Stefanie Anders; Michel K Herde; Andrea Delekate; Polina Gulakova; Susanne Schoch; Gabor C Petzold; Christian Henneberger
Journal:  Front Cell Neurosci       Date:  2021-06-04       Impact factor: 5.505

8.  Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease.

Authors:  Arianna Novati; Thomas Hentrich; Zinah Wassouf; Jonasz J Weber; Libo Yu-Taeger; Nicole Déglon; Huu Phuc Nguyen; Julia M Schulze-Hentrich
Journal:  Sci Rep       Date:  2018-04-11       Impact factor: 4.379

Review 9.  Transcriptional regulators of redox balance and other homeostatic processes with the potential to alter neurodegenerative disease trajectory.

Authors:  Scott W Burnside; Giles E Hardingham
Journal:  Biochem Soc Trans       Date:  2017-11-17       Impact factor: 5.407

10.  Stability, affinity, and chromatic variants of the glutamate sensor iGluSnFR.

Authors:  Jonathan S Marvin; Benjamin Scholl; Daniel E Wilson; Kaspar Podgorski; Abbas Kazemipour; Johannes Alexander Müller; Susanne Schoch; Francisco José Urra Quiroz; Nelson Rebola; Huan Bao; Justin P Little; Ariana N Tkachuk; Edward Cai; Adam W Hantman; Samuel S-H Wang; Victor J DePiero; Bart G Borghuis; Edwin R Chapman; Dirk Dietrich; David A DiGregorio; David Fitzpatrick; Loren L Looger
Journal:  Nat Methods       Date:  2018-10-30       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.